News Articles

On May 2, 2023 BVT announced a non-brokered private placement of 2,250,000 units (the “Units”) issued at a price of $0.12 per Unit for gross aggregate proceeds of $270,000 (the …

Read More

On April 18, 2023 BVT announced a new sales order with one of the largest berry growers in the Pacific Northwest.

Read More

On March 16, 2023 BVT announced that the Company’s CEO, Ashish Malik, will be presenting BVT’s most recent investor presentation, including an overview of current operations, recent achievements and upcoming …

Read More

On March 7, 2023 BVT announced positive second year trial results demonstrating the efficacy of BVT’s proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) as a seed treatment on …

Read More

On March 6, 2023 BVT announced that it has closed a non-brokered private placement of 1,491,667 units (the “Units”) issued at a price of $0.12 per Unit for gross aggregate …

Read More